These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19141144)

  • 1. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.
    Osborne NN
    Acta Ophthalmol; 2009 Jun; 87(4):450-4. PubMed ID: 19141144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
    Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
    Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
    Seki M; Lipton SA
    Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contemporary possibilities and perspectives in the treatment of glaucoma].
    Czepita D
    Ann Acad Med Stetin; 2005; 51(1):27-31. PubMed ID: 16496599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of memantine in progressive glaucoma. Case report].
    Schröder A; Erb C
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):533-6. PubMed ID: 12195321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of neuroprotection in glaucoma treatment.
    Osborne NN; Chidlow G; Nash MS; Wood JP
    Curr Opin Ophthalmol; 1999 Apr; 10(2):82-92. PubMed ID: 10537768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glaucoma neuroprotection--how far is it from a dream to reality].
    Ge J
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):385-7. PubMed ID: 18953889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological aspects in glaucoma].
    Istrate B
    Oftalmologia; 2010; 54(2):44-7. PubMed ID: 20827910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotection in glaucoma].
    Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
    Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection.
    Osborne NN; Núñez-Álvarez C; Joglar B; Del Olmo-Aguado S
    Eur J Pharmacol; 2016 Sep; 787():127-33. PubMed ID: 27090928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.
    Lorrio S; Negredo P; Roda JM; García AG; López MG
    Brain Res; 2009 Feb; 1254():128-37. PubMed ID: 19103181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.